QuidelOrtho Corp (QDEL)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $736.90M
Last updated: Nov 17, 2026 at 11:06 AM ET
QuidelOrtho Corp (QDEL) P/E Ratio & Valuation History
QuidelOrtho (QDEL) trades at 11.9x trailing earnings and 0.3x sales. Its P/E of 11.9x is below its 5-year median of 12.3x. Its forward P/E is 9.6x. The median P/E across 5 similar companies is 23.7x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 24.0% higher over the next year.
| Multiple | Value |
|---|---|
| P/E (trailing) | 11.9x |
| Forward P/E | 9.6x |
| Price to sales | 0.3x |
| Price to book | 0.4x |
| EV/EBITDA | 10.6x |
| PEG | 2.1 |
| FCF yield | -16.8% |
Historical Medians
Against its 10-year medians, its P/E is 24.2% below 15.7x, its P/S is 89.7% below 2.9x and its P/B is 87.1% below 3.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 11.9x | 12.3x | 15.7x |
| P/S | 0.3x | 1.1x | 2.9x |
| P/B | 0.4x | 0.9x | 3.1x |
Valuation History
Over the 9 of the 10 year ends shown that have a P/E, its P/E ranged from 4.9x in 2022 to 58.6x in 2017.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $28.56 | 13.5x | 0.7x | 1.0x |
| 2024 | $44.55 | 24.1x | 1.1x | 1.0x |
| 2023 | $73.70 | 17.8x | 1.6x | 1.0x |
| 2022 | $85.67 | 4.9x | 1.4x | 1.2x |
| 2021 | $134.99 | 7.6x | 3.4x | 3.0x |
| 2020 | $179.65 | 9.0x | 4.7x | 5.9x |
| 2019 | $75.03 | 25.3x | 6.0x | 5.8x |
| 2018 | $48.82 | 16.1x | 3.9x | 4.9x |
| 2017 | $43.35 | 58.6x | 5.3x | 6.6x |
| 2016 | $21.42 | N/A | 3.7x | 3.5x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About QDEL
What is QDEL's forward P/E ratio?
QuidelOrtho has a forward P/E ratio of 9.6x.
Is QDEL stock overvalued?
GNG's valuation label for QDEL is Undervalued. Its P/E of 11.9x compares with a median of 23.7x across 5 similar companies.
What is QDEL's price to sales ratio?
QuidelOrtho has a price to sales ratio of 0.3x.
What is QuidelOrtho's average P/E ratio over 5 years?
QuidelOrtho's median P/E over the last 5 years is 12.3x, from 60 month-end values through Oct 2026.
What is QDEL's PEG ratio?
QuidelOrtho has a PEG ratio of 2.1.
QDEL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts